Therapeutic Targeting of Interleukin-31 and Molecular Detection of c-KIT Mutations in Cutaneous Mast Cell Disorders: Supplementary Figure
Published: 2 March 2026| Version 1 | DOI: 10.17632/4h43stzwwz.1
Contributors:
Ajay Dulai, Emi Murase, Mihir Shah, Jenny MuraseDescription
Box plot demonstrating change in PP-NRS in 18 patients with recalcitrant itch with MCD (17 patients with symptomatic dermatographia and 1 patient with cutaneous mastocytosis), following initiation of nemolizumab. These patients with recalcitrant disease had failed an average of 15 different therapies (5.1 topical and 6.9 systemic) for itch prior to the initiation of nemolizumab.2
Files
Categories
Dermatology, Systemic Mastocytosis